A strategy to study pathway cross-talks of cells under repetitive exposure to stimuli

BMC Systems Biology

Volumn 6, Issue SUPPL3, 2012, Pages

  Fu, Yan ^a   Jiang, Xiaoshan ^a   Zhang, Hang ^a   Xing, Jianhua ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; PROTEOME; TRANSCRIPTOME;

ANIMAL; ARTICLE; CELL LINE; COMPUTER SIMULATION; CYTOLOGY; GENE EXPRESSION PROFILING; HUMAN; INNATE IMMUNITY; MACROPHAGE; METABOLISM; MICROARRAY ANALYSIS; PROTEIN BINDING; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

ANIMALS; CELL LINE; COMPUTER SIMULATION; CYTOKINES; ENDOTOXINS; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; MACROPHAGES; MICROARRAY ANALYSIS; PROTEIN BINDING; PROTEOME; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TRANSCRIPTOME;

MLCS; MLOWN;

EID: 84878857917     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-6-S3-S6     Document Type: Article

References (31)

1. Gardy JL, Lynn DJ, Brinkman FSL, Hancock REW. Enabling a systems biology approach to immunology: focus on innate immunity. Trends Immunol 2009, 30:249-262. 10.1016/j.it.2009.03.009, 19428301.
2. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604. 10.1016/j.immuni.2010.05.007, 20510870.
3. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004, 4:499-511. 10.1038/nri1391, 15229469.
4. Hu X, Ivashkiv LB. Cross-regulation of signaling pathways by interferon-[gamma]: implications for immune responses and autoimmune diseases. Immunity 2009, 31:539-550. 10.1016/j.immuni.2009.09.002, 2774226, 19833085.
5. Tyson JJ, Chen K, Novak B. Network dynamics and cell physiology. Nat Rev Mol Cell Biol 2001, 2:908-916. 10.1038/35103078, 11733770.
6. Tyson JJ, Chen KC, Novak B. Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Curr Opin Cell Biol 2003, 15:221-231. 10.1016/S0955-0674(03)00017-6, 12648679.
7. Alon U. An introduction to systems biology: Design principles of biological circuits 2007, Chapman and Hall/CRC, 1.
8. Natarajan M, Lin KM, Hsueh RC, Sternweis PC, Ranganathan R. A global analysis of cross-talk in a mammalian cellular signalling network. Nat Cell Biol 2006, 8:571-580. 10.1038/ncb1418, 16699502.
9. Cohen AA, Kalisky T, Mayo A, Geva-Zatorsky N, Danon T, Issaeva I, Kopito RB, Perzov N, Milo R, Sigal A, Alon U. Protein dynamics in individual human cells: experiment and theory. PLoS ONE 2009, 4:e4901. 10.1371/journal.pone.0004901, 2668709, 19381343.
10. Zhang XK, Morrison DC. Lipopolysaccharide-induced selective priming effects on tumor-necrosis-factor-alpha and nitric-oxide production in mouse peritoneal-macrophages. J Exp Med 1993, 177:511-516. 10.1084/jem.177.2.511, 2190891, 8426119.
11. Hu X, Herrero C, Li W-P, Antoniv TT, Falck-Pedersen E, Koch AE, Woods JM, Haines GK, Ivashkiv LB. Sensitization of IFN-[gamma] Jak-STAT signaling during macrophage activation. Nat Immunol 2002, 3:859-866.
12. West MA, Koons A. Endotoxin tolerance in sepsis: concentration-dependent augmentation or inhibition of LPS-stimulated macrophage TNF secretion by LPS pretreatment. J Trauma 2008, 65:893-898. discussion 898-900, 10.1097/TA.0b013e3181877fde, 18849808.
13. Shnyra A, Brewington R, Alipio A, Amura C, Morrison DC. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. J Immunol 1998, 160:3729-3736.
14. Hirohashi N, Morrison DC. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect Immun 1996, 64:1011-1015. 173871, 8641750.
15. Henricson BE, Manthey CL, Perera PY, Hamilton TA, Vogel SN. Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A. Infect Immun 1993, 61:2325-2333. 280852, 8388859.
16. Moreno-Navarrete JM, Manco M, Ibanez J, Garcia-Fuentes E, Ortega F, Gorostiaga E, Vendrell J, Izquierdo M, Martinez C, Nolfe G, et al. Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. Int J Obes (Lond) 2010, 34:240-249. 10.1038/ijo.2009.242, 19949414.
17. Wiesner P, Choi SH, Almazan F, Benner C, Huang W, Diehl CJ, Gonen A, Butler S, Witztum JL, Glass CK, Miller YI. Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circ Res 2010, 107:56-65. 10.1161/CIRCRESAHA.110.218420, 2904601, 20489162.
18. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, Willeit J. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001, 103:1064-1070. 10.1161/01.CIR.103.8.1064, 11222467.
19. Slofstra S, Cate H, Spek CA. Low dose endotoxin priming is accountable for coagulation abnormalities and organ damage observed in the Shwartzman reaction. A comparison between a single-dose endotoxemia model and a double-hit endotoxin-induced Shwartzman reaction. Thromb J 2006, 4:13. 10.1186/1477-9560-4-13, 1563996, 16930474.
20. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772. 10.2337/db06-1491, 17456850.
21. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481. 10.2337/db07-1403, 18305141.
22. Schoenborn JR, Wilson CB. Regulation of interferon-γ during innate and adaptive immune responses. Adv Immunol. Volume 2007, 96:41-101. Frederick WA: Academic Press.
23. Hu X, Chakravarty SD, Ivashkiv LB. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol Rev 2008, 226:41-56. 10.1111/j.1600-065X.2008.00707.x, 2630590, 19161415.
24. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75:163-189.
25. Fu Y, Glaros T, Zhu M, Wang P, Wu Z, Tyson JJ, Li L, Xing J. Network yopologies and dynamics leading to endotoxin tolerance and priming in innate immune cells. PLoS Comp Biol (In print) 2012, 3355072, 22615556.
26. Hu X, Park-Min KH, Ho HH, Ivashkiv LB. IFN-gamma-primed macrophages exhibit increased CCR2-dependent migration and altered IFN-gamma responses mediated by Stat1. J Immunol 2005, 175:3637-3647.
27. Vohradsky J. Neural network model of gene expression. FASEB J 2001, 15:846-854. 10.1096/fj.00-0361com, 11259403.
28. Sunahori K, Yamamura M, Yamana J, Takasugi K, Kawashima M, Yamamoto H, Chazin WJ, Nakatani Y, Yui S, Makino H. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther 2006, 8:R69. 10.1186/ar1939, 1526633, 16613612.
29. Asao H, Okuyama C, Kumaki S, Ishii N, Tsuchiya S, Foster D, Sugamura K. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol 2001, 167:1-5.
30. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007, 7:454-465. 10.1038/nri2093, 17525754.
31. Yamada S, Shiono S, Joo A, Yoshimura A. Control mechanism of JAK/STAT signal transduction pathway. FEBS Lett 2003, 534:190-196. 10.1016/S0014-5793(02)03842-5, 12527385.